Skip to content

EBITDA margin at other companies

Humana logo
HumanaHUM
3.4%-1.7pp
CVS Health logo
CVS HealthCVS
2.6%-1.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
5.2%-4.0pp
Astrana Health logo
Astrana HealthASTH
4%-0.9pp
Agilon Health logo
Agilon HealthAGL
-7%+6.8pp
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
11.3%+2.7pp

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Calculated from InnovAge Holdings, Inc.’s reported figures.

Based on trailing twelve months.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s EBITDA margin?
InnovAge Holdings, Inc. (INNV) reported EBITDA margin of 0.9% in Q1 2026.
How has InnovAge Holdings, Inc.'s EBITDA margin changed year-over-year?
InnovAge Holdings, Inc.'s EBITDA margin increased by 167.4% year-over-year, from -1.3% to 0.9%.
What is the long-term trend for InnovAge Holdings, Inc.'s EBITDA margin?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s EBITDA margin has grown at a -4.1% compound annual growth rate (CAGR), from 1.4% to -1.2%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.